✦ LIBER ✦

Cerebrospinal fluid biomarker outcomes in a trial of docosahexaenoic acid (DHA) for Alzheimer's disease

✍ Scribed by Joseph F. Quinn; Ronald Thomas; Rema Raman; Karin Yurko-Mauro; Eileen Bailey-Hall; Edward Nelson; Les Shaw; Paul Aisen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers of fatty acid oxidation in a

✍ Quinn, Joseph; Shinto, Lynne; Yurko-Mauro, Karin; Galasko, Douglas; Aisen, Paul; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Cerebrospinal fluid profiles of Aβ-relat

✍ Christoffer Rosén; Ulf Andreasson; Niklas Mattsson; Jan Marcusson; Lennart Minth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Identification of a novel panel of cereb

✍ A.H. Simonsen; J. McGuire; V.N. Podust; H. Davies; L. Minthon; I. Skoog; N. Andr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Cerebrospinal Fluid Biomarkers of Alzhei

✍ Shea, Y. F.; Chu, L.-W.; Zhou, L.; Li, W.-M.; Lin, O. Y.; Chan, M. N. Y.; Xu, A. 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 158 KB

β-Amyloid (Aβ) protein in cerebrospinal

✍ Niels Andreasen; Kaj Blennow 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Cost-Effectiveness of the Use of Biomark

✍ Valcárcel-Nazco, Cristina ;Perestelo-Pérez, Lilisbeth ;Molinuevo, José Luis ;Mar 📂 Article 📅 2014 🏛 IOS Press 🌐 English ⚖ 354 KB